• 1
    Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria and Explanatory Notes. New York, NY: Springer; 2010.
  • 2
    Abele JS, Levine RA. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cytopathol. 2010; 118: 415-422.
  • 3
    Henry M. The potential for overuse of atypical thyroid diagnoses. Cancer Cytopathol. 2011; doi:10.1002/cncy.20191.
  • 4
    Lang BH, Lo CY, Chan WF, et al. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging. Ann Surg Oncol. 2007; 14: 730-738.
  • 5
    Simpson WJ, McKinney SE, Carruthers JS, et al. Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med. 1987; 83: 479-488.
  • 6
    VanderLaan PA, Marqusee E, Krane JF. Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance. Am J Clin Pathol. 2011; 136: 572-577.
  • 7
    Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol. 2010; 38: 731-739.
  • 8
    Layfield LJ, Morton MJ, Cramer HM, et al. Implications of the proposed thyroid fine-needle aspiration category of “follicular lesion of undetermined significance”: a five-year multi-institutional analysis. Diagn Cytopathol. 2009; 37: 710-714.
  • 9
    Horne MJ, Chhieng DC, Theoharis C, et al. Thyroid follicular lesion of undetermined significance: evaluation of the risk of malignancy using the two-tier sub-classification. Diagn Cytopathol. 2011; doi:10.1002/dc.21790.
  • 10
    Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 2008; 130: 736-744.
  • 11
    Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004; 28: 1336-1340.
  • 12
    Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006; 107: 1255-1264.
  • 13
    Piana S, Frasoldati A, Di Felice E, et al. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol. 2010; 34: 868-872.
  • 14
    Vickery ALJr. Thyroid papillary carcinoma. Pathological and philosophical controversies. Am J Surg Pathol. 1983; 7: 797-807.
  • 15
    Williams ED; on behalf of the Chernobyl Pathologists Group ( Abrosimov A, Bogdanova T, Ilo M, Rosai J, Sidorov Y, Thomas GA). Guest editorial: Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol. 2000; 8: 181-183.
  • 16
    DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
  • 17
    Edge SE, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th edition. New York, NY: Springer; 2009.
  • 18
    Renshaw AA, Gould EW. Why there is the tendency to “overdiagnose” the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002; 117: 19-21.
  • 19
    American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009; 19: 1167-1214.
  • 20
    VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: Should repeat FNA be the preferred initial approach? Am J Clin Pathol. 2011; 135: 770-775.
  • 21
    Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid. 2009; 19: 1215-1223.
  • 22
    Logani S, Gupta PK, LiVolsi VA, et al. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol. 2000; 23: 380-385.
  • 23
    Jain M, Khan A, Patwardhan N, et al. Follicular variant of papillary thyroid carcinoma: a comparative study of histopathologic features and cytology results in 141 patients. Endocr Pract. 2001; 7: 79-84.
  • 24
    Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol. 2000; 13: 861-865.
  • 25
    Chan JK. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002; 117: 16-18.
  • 26
    Jo VY, Stelow EB, Dustin SM, et al. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2010; 134: 450-456.
  • 27
    Krane JF, Vanderlaan PA, Faquin WC, et al. The atypia of undetermined significance/follicular lesion of undetermined significance: malignant ratio: a proposed performance measure for reporting in The Bethesda System for Thyroid Cytopathology. Cancer Cytopathol. 2011; doi:10.1002/cncy.20192.
  • 28
    Renshaw AA. Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: Distinct patterns and associated risk of malignancy. Cancer Cytopathol. 2011; 119: 322-327.
  • 29
    Ohori NP, Nikiforova MN, Schoedel KE, et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance”. Cancer Cytopathol. 2010; 118: 17-23.
  • 30
    Nikiforov YE. Molecular analysis of thyroid tumors. Mod Pathol. 2011; 24: S34-S43.
  • 31
    Hassell, LA, Gillies EM, Dunn ST. Cytologic and molecular diagnosis of thyroid cancers. Is it time for routine reflex testing? Cancer Cytopathol. 2012; 120: 7-17.
  • 32
    Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab. 2003; 88: 5399-5404.